- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01219946
A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD) (COPD Language)
A Cross Sectional Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease and the Limitations of Patients' Activities in Primary Care.
Chronic obstructive pulmonary disease (COPD) is characterized by a progressive decline in lung function and increased symptoms such as breathlessness/dyspnoea, cough and expectoration.
Even though subjective in nature, the symptomatology of COPD and mainly that of breathlessness/dyspnoea has been studied with the use of objective measurement tools. Taking into consideration that the symptoms experienced by the patient who suffers from a progressive disease such as COPD can only be perceived and interpreted by the patient him- or herself, and thus difficult to be quantified, COPD remains a challenge in clinical research.
Therefore, there is a need to carry out qualitative studies that will provide insight into the wide spectrum of COPD symptomatology from the patient's perspective. In addition, a further mapping of the impact that COPD symptoms' perception has on a patient's life is required, as well as of the different pathways through which symptoms' perception is interpreted regarding the limitations of daily living activities, and the subsequent impact on disease management. The more the physician learns on the embodied experience of COPD, the better he/she may assist the patient in achieving optimal COPD management.
Thus this cross-sectional observational study was designed aiming to obtain these data. Specifically, the study aims to evaluate the most frequently used words by the patients and the physicians to express the symptoms of COPD as well as the limitation of activities that it causes.
Přehled studie
Postavení
Podmínky
Typ studie
Zápis (Aktuální)
Kontakty a umístění
Studijní místa
-
-
Attiki
-
Athina, Attiki, Řecko
- Research Site
-
Kalithea, Attiki, Řecko
- Research Site
-
Marousi, Attiki, Řecko
- Research Site
-
Megara, Attiki, Řecko
- Research Site
-
Nea Ionia, Attiki, Řecko
- Research Site
-
Nea Makri, Attiki, Řecko
- Research Site
-
Piraeus, Attiki, Řecko
- Research Site
-
-
Dodekanisa
-
Rodos, Dodekanisa, Řecko
- Research Site
-
-
Eptanisa
-
Kerkyra, Eptanisa, Řecko
- Research Site
-
-
Ipiros
-
Ioannina, Ipiros, Řecko
- Research Site
-
-
Kriti
-
Chania, Kriti, Řecko
- Research Site
-
Heraklion, Kriti, Řecko
- Research Site
-
-
Kyklades
-
Larisa, Kyklades, Řecko
- Research Site
-
Mykonos, Kyklades, Řecko
- Research Site
-
-
Makedonia
-
Alexandria, Makedonia, Řecko
- Research Site
-
Drama, Makedonia, Řecko
- Research Site
-
Florina, Makedonia, Řecko
- Research Site
-
Katerini, Makedonia, Řecko
- Research Site
-
Kavala, Makedonia, Řecko
- Research Site
-
Kozani, Makedonia, Řecko
- Research Site
-
Serres, Makedonia, Řecko
- Research Site
-
Thesaloniki, Makedonia, Řecko
- Research Site
-
-
Peloponisos
-
Krestena, Peloponisos, Řecko
- Research Site
-
Lechaina, Peloponisos, Řecko
- Research Site
-
Patra, Peloponisos, Řecko
- Research Site
-
Skala, Peloponisos, Řecko
- Research Site
-
-
Sterea
-
Agrinio, Sterea, Řecko
- Research Site
-
Halkida, Sterea, Řecko
- Research Site
-
Itea, Sterea, Řecko
- Research Site
-
Livadia, Sterea, Řecko
- Research Site
-
-
Thesalia
-
Volos, Thesalia, Řecko
- Research Site
-
-
Traki
-
Xanthi, Traki, Řecko
- Research Site
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
Popis
Inclusion Criteria:
- Aged 45-75 years
- Current or former smokers
- Known history of COPD for at least 6 months before enrolment into the study documented by spirometry (FEV1 /FVC <70%)
- Patients with stable COPD (no exacerbation within the last month before enrolment into the study) under treatment with a long-acting inhaled bronchodilator (LABA and/or LAMA) alone or in combination with an inhaled corticosteroid
- Written consent for participation in the study
- Patients who are able to complete by themselves in Greek a questionnaire on COPD.
Exclusion Criteria:
- Patients with diagnosed Asthma
- Patients with any psychiatric, neurological or other disorder render them unable to complete the COPD questionnaire by themselves
- The patient participates in another study.
Studijní plán
Jak je studie koncipována?
Detaily designu
Kohorty a intervence
Skupina / kohorta |
|---|
|
1
Patients with Chronic Obstructive Pulmonary Disease
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Časové okno |
|---|---|
|
Words used by the patients and the physicians to express the symptoms of COPD as well as the limitations of patients' daily living activities caused by COPD.
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Sekundární výstupní opatření
Měření výsledku |
Časové okno |
|---|---|
|
Stav
Časové okno: Konec náboru (odhadovaný časový rámec: 2,5 měsíce)
|
Konec náboru (odhadovaný časový rámec: 2,5 měsíce)
|
|
Obsazení
Časové okno: Konec náboru (odhadovaný časový rámec: 2,5 měsíce)
|
Konec náboru (odhadovaný časový rámec: 2,5 měsíce)
|
|
Age
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Gender
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Place of residence
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Native language
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Educational level
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Co-morbidities
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Years / months since COPD diagnosis and years with COPD symptoms
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Smoking history
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Number of exacerbations during the last year
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Current therapy
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
CCQ score
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Compliance with therapy
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Actions/therapeutic recommendations by the physician associated with each chosen word that express the chronic daily symptoms
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Scale for the assessment of the severity of the relevant symptoms
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Actions/therapeutic recommendations by the physician when any of the symptoms worsen
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Severity scale regarding how the patient experiences each of the chosen words that express the chronic daily symptoms
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Related actions initiated by the patient regarding chronic daily symptoms
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
|
Related actions initiated by the patient when the symptoms worsen.
Časové okno: End of recruitment (estimated timeframe :2.5 months)
|
End of recruitment (estimated timeframe :2.5 months)
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Ředitel studie: Panagiotis Pontikis
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- NIS-RGR-DUM-2010/1
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .